DATISTA PHARMA
Live / Applied — Fourth extension granted (statement of use) (as of 09 May 2025)
What this means for you
Not registered yet, but its 28 Mar 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97333298
- Mark type
- Stylized text
- Filed
- 28 Mar 2022
- Published for opposition
- 28 Mar 2023
- Attorney of record
- Andrew D. Bochner
Goods and services
- Class 005 — Pharmaceuticals: Medical, biological, and pharmaceutical preparations for treating diabetes for use in connection with humans and animals; Antibiotics, vitamins, and medicated oral and topical pharmaceuticals for treatment of diseases and disorders, namely, for treating diabetes
- Class 042 — Scientific and technological services: Scientific research and development in the fields of pharmaceuticals, medicine, and biotechnologies
Owner
- Effimed Investment Holdings LLC, Richmond, VA, US
- Effimed Investment Holdings LLC, Richmond, VA, US
Prosecution history
- 24 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 12 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 May 2025 — SOU EXTENSION 4 GRANTED
- 09 May 2025 — SOU EXTENSION 4 FILED
- 09 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Nov 2024 — SOU EXTENSION 3 GRANTED
- 25 Nov 2024 — SOU EXTENSION 3 FILED
- 25 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 18 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 May 2024 — SOU EXTENSION 2 GRANTED
- 17 May 2024 — SOU EXTENSION 2 FILED
- 17 May 2024 — SOU TEAS EXTENSION RECEIVED
- 17 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Aug 2023 — SOU EXTENSION 1 GRANTED